Position in BCRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$545,340
+$174,517 QoQ
Shares Held
54,534
+40.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#159
of 319 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AXQ CAPITAL, LP holds $9,179,081 across 16 Drug Manufacturers - Specialty & Generic names. BCRX ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
41,355 | $2,971,770 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
50,448 | $1,241,525 | |
| 3 | VTRS |
Viatris Inc
|
76,086 | $1,208,245 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
23,376 | $959,117 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
12,095 | $571,730 | |
| 6 | LQDA |
Liquidia Corp
|
6,846 | $545,831 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
54,534 | $545,340 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
9,572 | $242,841 |
All Filings in BCRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $545,340 | 54,534 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $370,823 | 38,952 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $443,430 | 58,423 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $119,320 | 13,317 | Shares | Sole | 2025-08-12 | |
| 2023-09-30 | $163,788 | 23,134 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $123,439 | 17,534 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $157,075 | 18,834 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||